Get started
Author

М. А. Абдуллаев

Observed names: Abdullaev, Musalitdin A., M A Abdullaev, M. A. Abdullaev, Musalitdin A. Abdullaev, Musalitdin Abdullaev, Musalitdin Absalamovich Abdullaev, Абдуллаев Мусалитдин Абсаламович, Абдуллаев, М.А., Абдуллаев, Мусалитдин
ORCID: 0000-0001-7374-2660
Observed ORCID: 0000-0001-7374-2660
OpenAlex ID: A5006411663
Pharmacogenetic Bases of Individual Sensitivity and Personalized Administration of Antiplatelet Therapy in Different Ethnic Groups
2021 · B. I. Kantemirova, E. A. Orlova, et al. · Pharmacy & Pharmacology · 9
PDF
Еstimation of Socio-economic Burden of Chronic Obstructive Pulmonary Disease for a 5-year Period: a Regional Aspect
2021 · E. A. Orlova, A. R. Umerova, et al. · Pharmacy & Pharmacology · 5
PDF
Pharmacoeconomic Evaluation of Anti-pneumococcal Vaccination in Risk Groups for the Prevention of Community-acquired Pneumonia Among Adults in the Astrakhan Region
2021 · E. A. Orlova, I. P. Dorfman, et al. · Pharmacy & Pharmacology · 4
PDF
Artificial intelligence in pharmacogenetics: A narrative review of current and future applications
2024 · M. A. Abdullaev, B. I. Kantemirova, et al. · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · 3
PDF
Economic Damage of Pneumococcal Vaccination Absence as a Risk Factor for Complications of Chronic Obstructive Pulmonary Disease
2022 · E. A. Orlova, I. P. Dorfman, et al. · Pharmacy & Pharmacology · 3
PDF
Bronchodilator and anti-inflammatory therapy of chronic obstructive pulmonary disease from the position of interchangeability
2021 · E. A. Orlova, I. P. Dorfman, et al. · PULMONOLOGIYA · 3
Factors influencing the effectiveness of antiplatelet therapy
2022 · Bela Kantemirova, Aleksei Zhidovinov, et al. · Archiv Euromedica · 2
PDF
Comparative study of the CYP2C19, CYP2C9, CYP4F2 gene polymorphisms impact on the clinical and laboratory characteristics of acute coronary syndrome patients
2023 · B. I. Kantemirova, M. A. Abdullaev, et al. · Pharmacogenetics and Pharmacogenomics · 1
PDF
Cost-utility Analysis of Personalized Antiplatelet Therapy
2023 · Musalitdin Abdullaev, B. Kantemirova, et al. · CASPIANJOURNALOF MEDICINE AND PHARMACY · 1
PDF
Features of COVID-19 etiopathogenetic pharmacotherapy
2024 · Alexandra Nikolaevna Romanova, Musalitdin Absalamovich Abdullaev, et al. · Medical news of the North Caucasus
PDF
Pharmacoeconomic analysis of personalized antiplatelet therapy in patients with acute coronary syndromer
2023 · M. A. Abdullaev, B. I. Kantemirova, et al. · Pharmacogenetics and Pharmacogenomics
PDF
The effect of polymorphic alleles carriage of the VKORC1 gene on clinical and laboratory parameters in patients with acute coronary syndrome
2022 · Bela I. Kantemirova, Elena N. Chernysheva, et al. · Kazan medical journal
The double bronchodilation era: new capabilities in a new drug delivery device
2022 · E. A. Orlova, I. P. Dorfman, et al. · Meditsinskiy sovet = Medical Council
PDF
Случай полиморфного носительства гена CYP2C19 у пациента с острым коронарным синдромом
2022 · М. А. Абдуллаев · Pharmacogenetics and Pharmacogenomics
PDF
Pharmacoeconomic Analysis of Inhalation Drugs Availability Used in COPD Treatment
2021 · Musalitdin A. Abdullaev, Anton I. Grechukhin, et al. · Health Food & Biotechnology
PDF
Pharmacogenetic Profile and Personalization Possibilitiesin Treatment of Patients With Chronic Pelvic Pain Syndrome
2021 · Regina Mamina, Bela Kantemirova, et al. · Archiv Euromedica
PDF
Актуальные вопросы вакцинопрофилактики хронической обструктивной болезни легких в условиях современной клинической практики
2020 · E. A. Orlova, I. P. Dorfman, et al. · CyberLeninK (CyberLeninka)
[Immunological status of patients with amebic abscess of the liver and its correction].
1990 · S P Gaĭbatov, M A Abdullaev · PubMed
Особенности этиопатогенетической фармакотерапии CO VID -19
· Романова Александра Николаевна, Абдуллаев Мусалитдин Абсаламович, et al. · CyberLeninK (CyberLeninka)
Works count: 30
Citation count: 37
H-index: 3
I10-index:
Year
Topic
Type